Tag: TGEN
-
NAU Counseling Services: Supporting Community Well-Being at the PBC
Life’s challenges don’t pause for busy schedules, and whether you’re a student, faculty member, or a professional in the Phoenix Bioscience Core (PBC) community, mental health support is essential. Northern Arizona University (NAU) North Valley Counseling Services is offering accessible, confidential counseling to not just NAU students, but also members of the general public who may need…
-
HonorHealth Research Institute taps leading anti-cancer drug development expert to head its new Center for Translational Science
Dr. Sunil Sharma’s medical prowess unifies basic scientific discoveries, translational drug development and clinical care to produce advanced treatments for patients Sunil Sharma, M.D., MBA, one of the nation’s leading experts in creating anti-cancer drugs, has been named director of HonorHealth Research Institute’s new Center for Translational Science. Dr. Sharma, who for more than three…
-
Canine Cancer Genome Project Enters Phase II -Omics
Focuses genomic and proteomic lenses on three canine cancers A team of researchers from Translational Genomics Research Institute (TGen), part of City of Hope, Ethos Discovery and Tufts University, has launched an extensive genomics and proteomics profiling study on Canine Osteosarcoma, B-cell Lymphoma, and Soft Tissue Sarcoma (STS). This initiative is part of the Canine Cancer Genome Project (CCGP), originally funded…
-
Unlocking the immune system’s potential to fight skin cancer
Karen Hastings, MD, PhD, is exploring how neoantigens can be used as a target for vaccines to help fight skin cancer. When Karen Hastings, MD, PhD, chose to make Arizona her home, it wasn’t just the stunning desert landscapes and towering saguaros that drew her in, it was the chance to confront one of the state’s most…
-
Shaping the Future: Highlights from the 2nd State of the PBC Event
On December 3, 2024, the Phoenix Bioscience Core (PBC) hosted its 2nd annual State of the PBC event, drawing over 180 attendees from notable institutions such as ASU, NAU, UA, Honor Health, Barrow Neurological Institute, City of Phoenix, the Flinn Foundation, and other key bioscience stakeholders. The event kicked off with a warm and energizing…
-
Introducing Investor Corner PBC: A New Hub for Investor-Company Connections
PHOENIX, AZ (January 8, 2025) – The Phoenix Bioscience Core (PBC) is proud to announce the launch of Investor Corner PBC — a dedicated space for investors to connect with innovators, entrepreneurs, and changemakers in the heart of Arizona’s bioscience ecosystem. Investor Corner is purposely situated within Connect Labs by Wexford, a flexible, scale-in-place lab…
-
Artist + Researcher Applications are open!
The Artist + Researcher program (ARx) at Phoenix Bioscience Core (PBC) is the largest initiative of the PBC Arts Committee, offering scientists the opportunity to collaborate with local artists to create pieces that visually interpret and communicate their scientific research and innovations. ARx was birthed in 2021 when the PBC connected with the Phoenix-based Bentley…
-
TGen Launches Center For Spatial Multi-Omics (COSMO): A Service Center Dedicated To Transforming Biomedical Research Through Spatial Biology
The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the launch of the Center for Spatial Multi-Omics (COSMO), a service center dedicated to transforming biomedical research through spatial biology. COSMO offers an unparalleled suite of services designed to help scientists visualize and map molecular data at the single-cell level directly within tissues. COSMO focuses…
-
TGen study reveals genetic drivers of common liver disease
Meta-analysis points to potential new therapeutic pathways PHOENIX, AZ — In the largest study of its kind, researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, have identified genes that appear to drive the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). Formerly known as non-alcoholic…
-
City of Hope appoints Aleksandar Sekulic to key cancer genomics role at TGen
City of Hope today announced the appointment of Aleksandar Sekulic, M.D., Ph.D., as a professor in the Integrated Cancer Genomics Division at Translational Genomics Research Institute (TGen).
